AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33422006 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative bevacizumab doses
Number of subjects: 382
Study 34706211 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training for 6 months
Number of subjects: 30
Study 33226845 — intervention group
Group type: EXPERIMENTAL
Intervention: KOOS Symptoms
Number of subjects: 113
Study 33226845 — intervention group
Group type: EXPERIMENTAL
Intervention: KOOS Pain
Number of subjects: 113
Study 33226845 — intervention group
Group type: EXPERIMENTAL
Intervention: KOOS Activities of Daily Living (ADL)
Number of subjects: 113
Study 33226845 — intervention group
Group type: EXPERIMENTAL
Intervention: KOOS Sports and Recreation
Number of subjects: 113
Study 33226845 — intervention group
Group type: EXPERIMENTAL
Intervention: KOOS Quality of Life (QOL)
Number of subjects: 113
Study 33226845 — intervention group
Group type: EXPERIMENTAL
Intervention: IKDC
Number of subjects: 113
Study 33226845 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysholm
Number of subjects: 113
Study 32912157 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (25 mg TID for 3 months followed by 50 mg TID for 3 months; n=30)
Number of subjects: 50
Study 32912157 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=20)
Number of subjects: 50
Study 33822654 — intervention group
Group type: EXPERIMENTAL
Intervention: Speech therapy services for 30 min twice weekly
Number of subjects: 35
Study 33822654 — intervention group
Group type: COMPARATOR
Intervention: Speech therapy services for 15 min 4 times weekly
Number of subjects: 35
Study 33386845 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with RHD
Number of subjects: 15400
Study 33386845 — intervention group
Group type: COMPARATOR
Intervention: Patients without RHD
Number of subjects: 15400
Study 33386845 — intervention group
Group type: EXPERIMENTAL
Intervention: CHA2DS2‐VASc score performance in patients with RHD
Number of subjects: 15400
Study 33386845 — intervention group
Group type: COMPARATOR
Intervention: CHA2DS2‐VASc score performance in patients without RHD
Number of subjects: 15400
Study 33386845 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitral stenosis
Number of subjects: 15400
Study 32223524 — intervention group
Group type: EXPERIMENTAL
Intervention: TSEgest
Number of subjects: 0
Study 32223524 — intervention group
Group type: EXPERIMENTAL
Intervention: RPSFTM
Number of subjects: 0
Study 32223524 — intervention group
Group type: EXPERIMENTAL
Intervention: TSEsimp
Number of subjects: 0
Study 32223524 — intervention group
Group type: EXPERIMENTAL
Intervention: IPCW
Number of subjects: 0
Study 34115578 — intervention group
Group type: EXPERIMENTAL
Intervention: Video of a clinician performing the neurologic examination
Number of subjects: 0
Study 34115578 — intervention group
Group type: EXPERIMENTAL
Intervention: Handout about the neurologic exam
Number of subjects: 0
Study 34115578 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplemental activities)
Number of subjects: 0
Study 34751672 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 patients (575 patients)
Number of subjects: 871
Study 34751672 — intervention group
Group type: COMPARATOR
Intervention: Control group (296 patients)
Number of subjects: 871
Study 34858021 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced dental cleaning
Number of subjects: 101
Study 34858021 — intervention group
Group type: COMPARATOR
Intervention: Control group (dental examination only)
Number of subjects: 101
Study 34858021 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbiome analysis
Number of subjects: 101
Study 32673591 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-h Time-Restricted Feeding (TRF)
Number of subjects: 0
Study 32673591 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-h Time-Restricted Feeding (TRF)
Number of subjects: 0
Study 32673591 — intervention group
Group type: COMPARATOR
Intervention: Control group (no meal timing restrictions)
Number of subjects: 0
Study 34320865 — intervention group
Group type: EXPERIMENTAL
Intervention: PECS-1 block with 0.4 mL kg−1 0.25% bupivacaine
Number of subjects: 120
Study 34320865 — intervention group
Group type: EXPERIMENTAL
Intervention: PECS-1 block
Number of subjects: 120
Study 34320865 — intervention group
Group type: COMPARATOR
Intervention: Infiltration anesthesia with 0.4 mL kg−1 0.25% bupivacaine
Number of subjects: 120
Study 36398740 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical power (MP) of ventilation
Number of subjects: 1962
Study 32761737 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycaemic index (LGI) diet (dietary GI = 40)
Number of subjects: 14
Study 32761737 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycaemic index (LGI) diet
Number of subjects: 14
Study 32761737 — intervention group
Group type: COMPARATOR
Intervention: High glycaemic index (HGI) diet (dietary GI = 60)
Number of subjects: 14
Study 34571187 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB) with 30 mL of 0.375% ropivacaine
Number of subjects: 68
Study 34571187 — intervention group
Group type: COMPARATOR
Intervention: Sham block with 30 mL of 0.9% saline
Number of subjects: 68
Study 34060942 — intervention group
Group type: EXPERIMENTAL
Intervention: Any intracranial hemorrhage
Number of subjects: 1097
Study 34060942 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenchymal hematoma type 1 (PH1)
Number of subjects: 1097
Study 34060942 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenchymal hematoma type 2 (PH2)
Number of subjects: 1097
Study 34060942 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemorrhagic infarction
Number of subjects: 1097
Study 32664105 — intervention group
Group type: COMPARATOR
Intervention: Conventional dose group A (120 kVp, 150 mAs)
Number of subjects: 60
Study 32664105 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose group B (120 kVp, 50 mAs)
Number of subjects: 60
Study 32664105 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose group C (100 kVp, 50 mAs)
Number of subjects: 60
Study 32664105 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose group D (100 kVp, 30 mAs)
Number of subjects: 60
Study 34871344 — intervention group
Group type: COMPARATOR
Intervention: MMS
Number of subjects: 3332
Study 34871344 — intervention group
Group type: COMPARATOR
Intervention: MQ-LNS
Number of subjects: 3332
Study 32132005 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 10426
Study 32303442 — intervention group
Group type: EXPERIMENTAL
Intervention: AP radiomics model
Number of subjects: 132
Study 32303442 — intervention group
Group type: EXPERIMENTAL
Intervention: PP radiomics model
Number of subjects: 132
Study 32980589 — intervention group
Group type: EXPERIMENTAL
Intervention: High loading condition (target +5% vertical ground reaction force)
Number of subjects: 12
Study 32980589 — intervention group
Group type: EXPERIMENTAL
Intervention: Low loading condition (target -5% vertical ground reaction force)
Number of subjects: 12
Study 32980589 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no cue)
Number of subjects: 12
Study 33728558 — intervention group
Group type: EXPERIMENTAL
Intervention: Cascading Model
Number of subjects: 150
Study 33728558 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning Collaborative
Number of subjects: 150
Study 33728558 — intervention group
Group type: EXPERIMENTAL
Intervention: Distance Education
Number of subjects: 150
Study 33728558 — intervention group
Group type: COMPARATOR
Intervention: Consultation calls
Number of subjects: 150
Study 32556601 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 36
Study 32556601 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 36
Study 34759247 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate surgery after chemotherapy (arm A)
Number of subjects: 206
Study 34759247 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard radiochemotherapy (capecitabine 50) plus surgery (arm B)
Number of subjects: 206
Study 34759247 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine 50 (arm C)
Number of subjects: 206
Study 34759247 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive radiochemotherapy (capecitabine 60; 60 Gy irradiation) (arm D)
Number of subjects: 206
Study 33439748 — intervention group
Group type: EXPERIMENTAL
Intervention: LEN and EPO alfa
Number of subjects: 195
Study 33439748 — intervention group
Group type: COMPARATOR
Intervention: LEN alone
Number of subjects: 195
Study 616593976 — intervention group
Group type: EXPERIMENTAL
Intervention: Team Nutriathlon (intervention group)
Number of subjects: 404
Study 616593976 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 404
Study 34930648 — intervention group
Group type: EXPERIMENTAL
Intervention: BariBoard™
Number of subjects: 201
Study 34930648 — intervention group
Group type: COMPARATOR
Intervention: Control (no BariBoard™)
Number of subjects: 201
Study 32393214 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual health counseling based on the transtheoretical model (TTM) for weight loss, lasting 6 months
Number of subjects: 86
Study 32393214 — intervention group
Group type: COMPARATOR
Intervention: Usual care (comparison group)
Number of subjects: 86
Study 35081010 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (4 mg twice daily for 48 hours)
Number of subjects: 80
Study 35081010 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 35081010 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 80
Study 33640257 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender aromatherapy (inhalation for five minutes, three times a week)
Number of subjects: 0
Study 33640257 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender aromatherapy
Number of subjects: 0
Study 33640257 — intervention group
Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 0
Study 35492241 — intervention group
Group type: EXPERIMENTAL
Intervention: LEAP2 infusion
Number of subjects: 20
Study 35492241 — intervention group
Group type: EXPERIMENTAL
Intervention: LEAP2 dosing in wild-type mice
Number of subjects: 20
Study 35492241 — intervention group
Group type: COMPARATOR
Intervention: GHSR-null mice
Number of subjects: 20
Study 34642836 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 30
Study 34642836 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 30
Study 34642836 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 33926724 — intervention group
Group type: EXPERIMENTAL
Intervention: Fault detection performance index based on stochastic robustness/sensitivity ratio; specific dosage and duration not mentioned.
Number of subjects: 0
Study 33926724 — intervention group
Group type: EXPERIMENTAL
Intervention: Fault detection threshold setting algorithms using Randomized Algorithms; specific dosage and duration not mentioned.
Number of subjects: 0
Study 32029684 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous group (PCV13, DTaP, and IIV4 at visit 1)
Number of subjects: 221
Study 32029684 — intervention group
Group type: COMPARATOR
Intervention: Sequential group (PCV13 and DTaP at visit 1, IIV4 at visit 2)
Number of subjects: 221
Study 33780999 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of USPSTF guidelines for adolescent obesity management
Number of subjects: 18
Study 33780999 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexibility within weight management programs
Number of subjects: 18
Study 33327339 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized diabetes education
Number of subjects: 100
Study 33327339 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 100
Study 35599143 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Early Warning Score (I‐EWS)
Number of subjects: 90464
Study 35599143 — intervention group
Group type: COMPARATOR
Intervention: National Early Warning Score (NEWS)
Number of subjects: 90464
Study 33413707 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall Glycaemic Index (GI)
Number of subjects: 734
Study 33413707 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall Glycaemic Load (GL)
Number of subjects: 734
Study 32243660 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) + Game therapy (GT)
Number of subjects: 32
Study 32243660 — intervention group
Group type: COMPARATOR
Intervention: Pelvic floor muscle training (PFMT) isolated
Number of subjects: 32
Study 35325969 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypochloric acid (100 μg/mL)
Number of subjects: 41
Study 35325969 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypochloric acid (1, 2, 4, 8 times of MBEC)
Number of subjects: 41
Study 35325969 — intervention group
Group type: COMPARATOR
Intervention: Povidone iodine (50 mg/mL)
Number of subjects: 41
Study 32459885 — intervention group
Group type: EXPERIMENTAL
Intervention: Opicapone 25 mg tablet
Number of subjects: 48
Study 32459885 — intervention group
Group type: EXPERIMENTAL
Intervention: Opicapone 50 mg tablet
Number of subjects: 48
Study 32459885 — intervention group
Group type: COMPARATOR
Intervention: Opicapone 25 mg capsule
Number of subjects: 48
Study 32459885 — intervention group
Group type: COMPARATOR
Intervention: Opicapone 50 mg capsule
Number of subjects: 48
Study 32619857 — intervention group
Group type: EXPERIMENTAL
Intervention: Registry-based RCTs
Number of subjects: 1000
Study 35213293 — intervention group
Group type: EXPERIMENTAL
Intervention: Respond to Prevent intervention (integrated educational toolkits and streamlined materials)
Number of subjects: 175
Study 33043697 — intervention group
Group type: COMPARATOR
Intervention: SET3
Number of subjects: 38
Study 33043697 — intervention group
Group type: COMPARATOR
Intervention: SET1
Number of subjects: 38
Study 34609490 — intervention group
Group type: EXPERIMENTAL
Intervention: High VZV circulation countries
Number of subjects: 17
Study 34609490 — intervention group
Group type: COMPARATOR
Intervention: Moderate VZV circulation countries
Number of subjects: 17
Study 34609490 — intervention group
Group type: COMPARATOR
Intervention: Low VZV circulation countries
Number of subjects: 17
Study 33016680 — intervention group
Group type: EXPERIMENTAL
Intervention: Exoskeleton (ExoAtlet) rehabilitation exercises (5 days a week for 2 weeks)
Number of subjects: 47
Study 33016680 — intervention group
Group type: COMPARATOR
Intervention: Active-passive pedal exercise bike rehabilitation exercises (5 days a week for 2 weeks)
Number of subjects: 47
Study 33938704 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive management with Cal/BD foam
Number of subjects: 0
Study 33938704 — intervention group
Group type: COMPARATOR
Intervention: Reactive management with Cal/BD foam
Number of subjects: 0
Study 33938704 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive management during remission periods
Number of subjects: 0
Study 33938704 — intervention group
Group type: COMPARATOR
Intervention: Reactive management during remission periods
Number of subjects: 0
Study 33938704 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive management during relapse periods
Number of subjects: 0
Study 33938704 — intervention group
Group type: COMPARATOR
Intervention: Reactive management during relapse periods
Number of subjects: 0
Study 33938704 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive management for patients who dropped out
Number of subjects: 0
Study 33938704 — intervention group
Group type: COMPARATOR
Intervention: Reactive management for patients who dropped out
Number of subjects: 0
Study 34689288 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (oral prednisolone 60 mg daily with gradual taper-off to 35 mg/day and cyclosporine 3 mg/kg/day)
Number of subjects: 70
Study 34689288 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid therapy (methylprednisolone 1000 mg for 3 days followed by oral prednisolone)
Number of subjects: 70
Study 34689288 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 70
Study 34689288 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid therapy
Number of subjects: 70
Study 32014538 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother-Child Education Program (MOCEP)
Number of subjects: 106
Study 32014538 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 106
Study 34309576 — intervention group
Group type: EXPERIMENTAL
Intervention: eB2 app users (24 participants, 31%)
Number of subjects: 77
Study 34309576 — intervention group
Group type: EXPERIMENTAL
Intervention: eB2 app users
Number of subjects: 77
Study 34309576 — intervention group
Group type: COMPARATOR
Intervention: Nonusers (53 participants, 69%)
Number of subjects: 77
Study 34468079 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-intestinal release peppermint oil
Number of subjects: 126
Study 34468079 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 35120773 — intervention group
Group type: EXPERIMENTAL
Intervention: Screen-detected prostate cancer (PC)
Number of subjects: 10000
Study 32598793 — intervention group
Group type: EXPERIMENTAL
Intervention: Enisamium iodide with symptomatic therapy
Number of subjects: 134
Study 32598793 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic therapy only (Control)
Number of subjects: 134
Study 35110688 — intervention group
Group type: EXPERIMENTAL
Intervention: THC (7.5, 15 mg)
Number of subjects: 24
Study 35110688 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 33315812 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (50%-70% of heart rate reserve, 3-4 days/week for 25-40 min)
Number of subjects: 59
Study 33315812 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 59
Study 34969411 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing meditation training
Number of subjects: 40
Study 34969411 — intervention group
Group type: COMPARATOR
Intervention: Routine training
Number of subjects: 40
Study 33051039 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 158
Study 33051039 — intervention group
Group type: COMPARATOR
Intervention: Music Therapy-Based Stress Reduction (MTSR)
Number of subjects: 158
Study 35601567 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing intervention based on health belief model (HBM)
Number of subjects: 60
Study 33377716 — intervention group
Group type: EXPERIMENTAL
Intervention: Priligy (dapoxetine hydrochloride) 30 mg 1-3 hours before sexual activity combined with behavioral therapy and psychological counseling (30 minutes, once a month for two times)
Number of subjects: 202
Study 33377716 — intervention group
Group type: COMPARATOR
Intervention: Priligy (dapoxetine hydrochloride) 30 mg 1-3 hours before sexual activity
Number of subjects: 202
Study 34836715 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet with 12‐h time restricted feeding
Number of subjects: 120
Study 34836715 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet without time restricted feeding
Number of subjects: 120
Study 34836715 — intervention group
Group type: COMPARATOR
Intervention: Standard Australian Dietary Guidelines (ADG)
Number of subjects: 120
Study 34836715 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (MedDiet with/without TRF and ADG)
Number of subjects: 120
Study 33993795 — intervention group
Group type: EXPERIMENTAL
Intervention: Reperfusion therapy
Number of subjects: 415
Study 33993795 — intervention group
Group type: COMPARATOR
Intervention: No reperfusion
Number of subjects: 415
Study 33993795 — intervention group
Group type: EXPERIMENTAL
Intervention: Core volume
Number of subjects: 415
Study 32755831 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based lifestyle modification intervention using the DIAGURU mobile application for 6 months.
Number of subjects: 300
Study 32755831 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-intervention).
Number of subjects: 300
Study 36412415 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 cycles of single agent, 3 weekly injection paclitaxel 175 mg/m2 as maintenance therapy
Number of subjects: 300
Study 36412415 — intervention group
Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 300
Study 34684429 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine tartrate supplementation
Number of subjects: 80
Study 34684429 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 35733135 — intervention group
Group type: EXPERIMENTAL
Intervention: VR Basic Life Support (BLS) training
Number of subjects: 88
Study 33400778 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvanted trivalent influenza vaccine (aTIV)
Number of subjects: 777
Study 33400778 — intervention group
Group type: COMPARATOR
Intervention: Trivalent influenza vaccine (TIV)
Number of subjects: 777
Study 36215334 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass drug administration (MDA) + snail control
Number of subjects: 176
Study 36215334 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass drug administration (MDA) alone
Number of subjects: 176
Study 36215334 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass drug administration (MDA) + behavioral change interventions
Number of subjects: 176
Study 36215334 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 176
Study 32840412 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (100 mg daily for seven days)
Number of subjects: 20
Study 32840412 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxithromycin (300 mg daily for seven days)
Number of subjects: 20
Study 33932114 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent ADT (IADT)
Number of subjects: 303
Study 33932114 — intervention group
Group type: COMPARATOR
Intervention: Continuous ADT (CADT)
Number of subjects: 303
Study 32502243 — intervention group
Group type: EXPERIMENTAL
Intervention: High phosphorus intake (≥ 1375 mg/d)
Number of subjects: 20
Study 32502243 — intervention group
Group type: EXPERIMENTAL
Intervention: Low phosphorus intake (< 1100 mg/d)
Number of subjects: 20
Study 32502243 — intervention group
Group type: EXPERIMENTAL
Intervention: Very high calcium intake
Number of subjects: 20
Study 32502243 — intervention group
Group type: EXPERIMENTAL
Intervention: Very low calcium intake
Number of subjects: 20
Study 32502243 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased Ca/P ratio
Number of subjects: 20
Study 32502243 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased Ca/P ratio
Number of subjects: 20